After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30%
After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu SC asks why drug price caps cover only cancer medicines, flags huge mark-ups on medical supplies Telegraph India Panel to finalise cancer drugs for 30% trade...
Key Takeaways
- After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30%
- After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu SC asks why drug price caps cover only cancer medicines, flags huge mark-ups on medical supplies Telegraph India Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possible The Economic Times Cancer drug price cuts may vary despite 30% trade margin cap pharma.economictimes.indiatimes.com
- Click full coverage link below for the complete official dispatch.
After Supreme Court Push, Centre To Cap Cancer Drug Margins At 30% Live Law Supreme Court wants cap on trade margin for all essential medicines and medical products The Hindu SC asks why drug price caps cover only cancer medicines, flags huge mark-ups on medical supplies Telegraph India Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possible The Economic Times Cancer drug price cuts may vary despite 30% trade margin cap pharma.economictimes.indiatimes.com
Original Publisher Attribution
This summary was curated from Live Law.